ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund trimmed its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 65.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,137 shares of the medical instruments supplier's stock after selling 32,141 shares during the quarter. New York State Common Retirement Fund owned approximately 0.07% of ICU Medical worth $2,659,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp increased its stake in ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock worth $165,384,000 after purchasing an additional 77,506 shares during the period. Geode Capital Management LLC increased its stake in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after buying an additional 48,106 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in ICU Medical by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier's stock valued at $54,868,000 after buying an additional 27,927 shares in the last quarter. WCM Investment Management LLC boosted its position in ICU Medical by 1.3% in the 3rd quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier's stock valued at $45,272,000 after buying an additional 3,407 shares during the period. Finally, Victory Capital Management Inc. grew its stake in ICU Medical by 0.5% in the 3rd quarter. Victory Capital Management Inc. now owns 142,535 shares of the medical instruments supplier's stock worth $25,973,000 after acquiring an additional 687 shares in the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

ICU Medical Stock Up 1.9 %

ICU Medical stock traded up $2.62 during mid-day trading on Wednesday, reaching $143.57. 294,876 shares of the company were exchanged, compared to its average volume of 218,228. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The business has a fifty day moving average of $159.84 and a 200 day moving average of $166.08. The firm has a market cap of $3.52 billion, a P/E ratio of -31.42 and a beta of 0.63. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Insider Buying and Selling

In related news, CEO Vivek Jain sold 1,373 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 6.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ICUI has been the subject of several research analyst reports. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, November 20th. KeyCorp upped their target price on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a report on Wednesday, November 13th. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a research report on Wednesday, December 11th. Finally, Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, ICU Medical has an average rating of "Moderate Buy" and an average price target of $199.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.